Faculty

Writing for Science, Prof. Gang Chen emphasizes the need for universities and funding agencies to stand up for faculty who are wrongfully prosecuted. “What gave me hope and ultimately saved me is a lesson for all universities. MIT leadership, under President L. Rafael Reif, supported me morally and financially after I was detained at the airport, and the university made its support public soon after I was arrested,” writes Chen. He adds, “I urge university leaders, trustees, and alumni associations to protect their faculty from a campaign that is misdirected. The talent loss and terror lobbed upon faculty are weakening their institutions, supporting harmful bias, and ruining lives.”

Jim Axelrod of CBS News speaks with Professor Gang Chen about his ordeal following charges he faced – all now dismissed – under the “China Initiative.” Describing the accusations against Chen as “a massive jolt,” President L. Rafael Reif said, “I felt it was an attack on all Chinese Americans in America, particularly in academia.” Added Chen, a U.S. citizen for more than two decades, “We thought we had achieved the American Dream. Until this nightmare happened.”

Prof. Kate Brown speaks with Verge reporter Justine Calma about the potential implications of fighting in the containment zone around Chernobyl. “It’s a continuing problem,” Brown says. “It’s supposed to be contained. It’s supposed to be left untouched. And that’s the problem with any kind of nuclear site. It demands stability and peace.”

David Lucchino ’06 and Prof. Robert Langer have co-founded Frequency Therapeutics, a biotechnology company focused on developing a new approach to restoring hearing from the most common form of hearing loss, reports Jack Kelly for Forbes. “FX-322 is designed to treat the underlying cause of SNHL (sensorineural hearing loss) by regenerating sensory hair cells through activation of progenitor cells already present in the cochlea,” writes Kelly.

Provost Martin Schmidt speaks with Tech reporter Caroline Powers about his proudest accomplishments as MIT’s senior academic officer, what he will miss most about MIT and the importance of integrating ethics into engineering education. “I’m going to miss the interactions I’ve had with the students and my faculty colleagues,” notes Schmidt. “Part of the joy of being here has been making those relationships and working together.”

President L. Rafael Reif, who bolstered MIT’s stature "as a hub of tech innovation,” is stepping down at the end of 2022, reports the AP. "His achievements include the creation of a new business incubator in 2016 to help scholars turn big ideas into companies,” writes the AP. “In 2018, he announced a $1 billion investment in artificial intelligence and computing, centered around a new College of Computing that aims to apply AI technology across all academic disciplines.”

Bloomberg News spotlights how President L. Rafael Reif, who “oversaw a revitalization of MIT’s campus and its continued integration with Kendall Square” has announced he will step down at the end of 2022. “Reif’s emphases as provost and president included the shift to more online learning, and innovation in ‘tough tech,’ including the creation of 'The Engine,' an incubator supporting companies to solve the world’s greatest challenges, from fusion energy to new medical devices.”

President L. Rafael Reif, who was "instrumental in leading [MIT] to convert its science into innovation, especially in the areas of life sciences, energy, materials, and machine learning and artificial intelligence,” has announced he will step down at the end of 2022, reports Laura Krantz for The Boston Globe. “What I felt was special about Rafael as president was his humanity,” says Prof. Caroline Jones. “He understood when there were problems that couldn’t be solved by technology.”

In an article for The Washington Post, Visiting Professor Susan Blumenthal and Emily Stark of New America make the case for creating a “government-backed program that would evaluate and label masks for consumers like the Food and Drug Administration does for sunscreens.”

Prof. Mircea Dincǎ, Prof. Evelyn Ning-Yi Wang, Prof. Ian W. Hunter, Prof. Guoping Feng, and Senior Research Scientist David H. Shoemaker were elected as Fellows of AAAS for their efforts on behalf of the advancement of science and its applications to better serve society, reports Science.

Prof. Gang Chen speaks with New York Times reporter Ellen Barry about the damage inflicted by the “China Initiative.” “My love is science. I did not want politics, right?” says Chen. “But I learned that you can’t get away. Politics impacts everybody. So if there are things that are not right, we all need to speak out.”

Writing for The Boston Globe, Prof. Gang Chen calls for a thorough review of the Justice Department’s China Initiative and the “critical mistakes on the part of the FBI, federal prosecutors, and other federal investigative agencies.” Chen writes: “As a nation, we can be more true to our ideals — and a better world leader — by acknowledging our wrongdoings and learning from our mistakes rather than blindly pressing forward.”

In a letter to the Financial Times, Prof. Donald Sadoway underscores the need for new smelting capacity to meet the growing need for copper for the transition to clean energy. “Imagine a process that produces superior metal at lower cost with zero greenhouse gas emissions,” writes Sadoway. “Such technology would recapture domestic market share from foreign producers. We must invent the future; we cannot simply legislate for it.”

New York Times reporter Steve Lohr spotlights Institute Prof. Daron Acemoglu’s research showing that “excessive automation” has contributed to rising inequality. “We need to redirect technology so it works for people,” says Acemoglu, “not against them.”

Prof. Justin Reich speaks with GBH’s Meg Woolhouse about the importance of addressing longstanding inequities in the education system. “It’s about creating a more equitable world where,” says Reich, “every kid in Boston has high-speed internet in their house, and has technology access, and has access to high-quality medical care and testing and things like that.”